Cysteine Protease Inhibitors Produced by the Industrial Koji Mold, Aspergillus oryzae O-1018

T Yamada1, J Hiratake2, M Aikawa1

  • 1a Research Institute, Gekkeikan Sake Co. Ltd.

Insights

Five novel papain-inhibitory compounds, CPI-1 to CPI-5, were isolated from Aspergillus oryzae. These compounds exhibit potent cysteine protease inhibition, with some being significantly more effective than E-64.

Area of Science:

  • Biochemistry
  • Microbiology
  • Enzymology

Background:

  • Aspergillus oryzae is utilized in industrial sake brewing.
  • Papain is a cysteine protease with various applications.
  • The search for novel protease inhibitors is ongoing.

Purpose of the Study:

  • To isolate and characterize papain-inhibitory compounds produced by Aspergillus oryzae O-1018.
  • To elucidate the structures of these novel inhibitors.
  • To evaluate their inhibitory activity against cysteine proteases.

Main Methods:

  • Fermentation of Aspergillus oryzae O-1018.
  • Isolation and purification of inhibitory compounds using chromatography.
  • Structure elucidation via spectroscopic analyses (NMR, MS) and chemical degradation.
  • Enzyme inhibition assays against cysteine proteases like cathepsin B and L.

Main Results:

  • Five papain-inhibitory compounds, designated CPI-1 to CPI-5, were isolated.
  • Structures of CPI-2, CPI-3, and CPI-4 were determined as novel compounds.
  • CPI-1 and CPI-5 were identified as combinations of L-trans-epoxysuccinic acid, amino acids, and spermidine.
  • All CPIs demonstrated specific inhibition of cysteine proteases, with CPI-1 and CPI-5 showing superior inhibition against cathepsin L compared to E-64.

Conclusions:

  • Aspergillus oryzae O-1018 produces novel cysteine protease inhibitors.
  • The identified CPIs possess significant inhibitory potential against cathepsin B and L.
  • These compounds represent promising candidates for therapeutic or research applications targeting cysteine proteases.